Skip to main content
Clinical Trials/NCT05938543
NCT05938543
Recruiting
N/A

Noninvasive Neuromodulation of a Novel Cerebellar Satiety Circuit in Prader-Willi Syndrome

Brigham and Women's Hospital1 site in 1 country20 target enrollmentSeptember 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prader-Willi Syndrome
Sponsor
Brigham and Women's Hospital
Enrollment
20
Locations
1
Primary Endpoint
Retention of subjects in study assessments
Status
Recruiting
Last Updated
4 months ago

Overview

Brief Summary

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study hyperphagia and satiety in Prader-Willi syndrome.

TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study, the investigators will be stimulating the brain to learn more about how TMS might improve hyperphagia in Prader-Willi syndrome.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
October 1, 2026
Last Updated
4 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Laura M Holsen

Associate Professor of Psychiatry

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Prader-Willi syndrome

Exclusion Criteria

  • contraindications for TMS or MRI including :
  • history of neurological disorder
  • history of head trauma resulting in loss of consciousness
  • history of seizures or diagnosis of epilepsy or first degree relative family history of epilepsy
  • metal in brain or skull
  • implanted devices such as a pacemaker, medication pump, nerve stimulator or ventriculoperitoneal shunt claustrophobic in MRI

Outcomes

Primary Outcomes

Retention of subjects in study assessments

Time Frame: 1-week post-TMS follow-up visit

Retention of subjects for assessments at baseline and 1-week post-TMS follow-up visit, as measured by the percentage (%) of enrolled subjects who complete baseline assessments and then go on to complete the 1-week post-TMS follow-up visit.

Time required to enroll subjects into study

Time Frame: At study completion, up to 18 months

Time required to enroll the target sample size (n=12) into the study

Change in BOLD response

Time Frame: baseline, 1-week post-TMS follow-up visit

Change in functional activation of the cerebellum and ventral striatum will be assessed before (baseline) and after TMS stimulation (1-week post-TMS follow-up visit)

Study Sites (1)

Loading locations...

Similar Trials